(Q43629639)

25 November 2017

Speech dysfluency exacerbated by levodopa in Parkinson's disease (English)

1 reference

25 November 2017

1 reference

1 reference

3

Fahn S

1 reference

25 November 2017

1

Louis ED

1 reference

25 November 2017

Winfield L

2

1 reference

PubMed ID

11391759

25 November 2017

Ford B

series ordinal

4

1 reference

PubMed ID

11391759

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

16

1 reference

25 November 2017

3

1 reference

25 November 2017

562-565

1 reference

The pharmacology of stuttering: a critical review

25 November 2017

1 reference

An investigation into the relationship between anxiety and stuttering.

21 January 2018

1 reference

Parkinsonism and basal ganglia infarcts.

21 January 2018

1 reference

Site of penetrating brain lesions causing chronic acquired stuttering.

21 January 2018

1 reference

Stuttering as a manifestation of right-hemispheric subcortical stroke.

21 January 2018

1 reference

Developmental stuttering and Parkinson's disease: the effects of levodopa treatment

21 January 2018

1 reference

Language disintegration in dementia: effects of etiology and severity

21 January 2018

1 reference

Speech disorders of Parkinsonism: a review

21 January 2018

1 reference

"On-Off" Phenomena Related to High Plasma Levodopa

21 January 2018

1 reference

Letter: Peak-dose dysphonia in parkinsonism

21 January 2018

1 reference

Clozapine-induced stuttering: epileptic brain activity?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.1081

1 reference

25 November 2017

1 reference

PubMed ID

11391759